Andrew John Li

Summary

Affiliation: Cedars-Sinai Medical Center
Country: USA

Publications

  1. ncbi Surgical advances in the treatment of ovarian cancer
    Andrew J Li
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    Hematol Oncol Clin North Am 17:945-56. 2003
  2. ncbi AIB1 polymorphisms predict aggressive ovarian cancer phenotype
    Andrew J Li
    Department of Obstetrics and Gynecology, Cedars Sinai Medical Center, 8700 Beverly Boulevard, Suite 160W, Los Angeles, CA 90048, USA
    Cancer Epidemiol Biomarkers Prev 14:2919-22. 2005
  3. ncbi Hyperandrogenism, mediated by obesity and receptor polymorphisms, promotes aggressive epithelial ovarian cancer biology
    Andrew J Li
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Cedars Sinai Medical Center, 8700 Beverly Blvd, Suite 160W, Los Angeles, CA 90048, USA
    Gynecol Oncol 107:420-3. 2007
  4. doi Androgen receptor cytosine-adenine-guanine repeat polymorphisms modulate EGFR signaling in epithelial ovarian carcinomas
    Andrew J Li
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Cedars Sinai Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90048, USA
    Gynecol Oncol 109:220-5. 2008
  5. ncbi The prognostic significance of thrombocytosis in epithelial ovarian carcinoma
    Andrew J Li
    Department of Obstetrics and Gynecology, Cedars Sinai Medical Center, Geffen School of Medicine at UCLA, Los Angeles, CA 90048, USA
    Gynecol Oncol 92:211-4. 2004
  6. ncbi Androgen mediation of thrombocytosis in epithelial ovarian cancer biology
    Andrew John Li
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars Sinai Medical Center, Los Angeles, California 90048, USA
    Clin Cancer Res 11:8015-8. 2005
  7. ncbi Ovarian preservation in stage I low-grade endometrial stromal sarcomas
    Andrew J Li
    Department of Obstetrics Gynecology, Cedars Sinai Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90048, USA
    Obstet Gynecol 106:1304-8. 2005
  8. doi Impact of androgen receptor cytosine-adenine-guanine polymorphisms on clinical outcome in BRCA mutation-associated epithelial ovarian cancers
    Andrew J Li
    Department of Obstetrics and Gynecology, Cedars Sinai Medical Center, 8700 Beverly Blvd, Suite 160W, Los Angeles, CA 90048, USA
    Gynecol Oncol 116:105-8. 2010
  9. doi Serum low-density lipoprotein levels correlate with survival in advanced stage epithelial ovarian cancers
    Andrew J Li
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Cedars Sinai Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90048, USA
    Gynecol Oncol 116:78-81. 2010
  10. ncbi Hereditary ovarian cancer--assessing risk and prevention strategies
    James C Pavelka
    Cedars Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA
    Obstet Gynecol Clin North Am 34:651-65, vii-viii. 2007

Collaborators

Detail Information

Publications20

  1. ncbi Surgical advances in the treatment of ovarian cancer
    Andrew J Li
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    Hematol Oncol Clin North Am 17:945-56. 2003
    ..Although laparoscopy may be feasible in staging women with disease apparently limited to an ovary, further studies are necessary before it can be considered routinely as an alternative to standard laparotomy...
  2. ncbi AIB1 polymorphisms predict aggressive ovarian cancer phenotype
    Andrew J Li
    Department of Obstetrics and Gynecology, Cedars Sinai Medical Center, 8700 Beverly Boulevard, Suite 160W, Los Angeles, CA 90048, USA
    Cancer Epidemiol Biomarkers Prev 14:2919-22. 2005
    ..We hypothesized that genotypic variations in the androgen-signaling pathway promote aggressive epithelial ovarian cancer biology, and sought to examine the effect of AIB1 genotype on clinical outcome...
  3. ncbi Hyperandrogenism, mediated by obesity and receptor polymorphisms, promotes aggressive epithelial ovarian cancer biology
    Andrew J Li
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Cedars Sinai Medical Center, 8700 Beverly Blvd, Suite 160W, Los Angeles, CA 90048, USA
    Gynecol Oncol 107:420-3. 2007
    ..We have hypothesized that the combination of these factors further manifests an aggressive ovarian cancer phenotype...
  4. doi Androgen receptor cytosine-adenine-guanine repeat polymorphisms modulate EGFR signaling in epithelial ovarian carcinomas
    Andrew J Li
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Cedars Sinai Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90048, USA
    Gynecol Oncol 109:220-5. 2008
    ..We hypothesize short AR allelotypes promote aggressive ovarian cancer phenotype through modulation of epidermal growth factor receptor (EGFR) signaling...
  5. ncbi The prognostic significance of thrombocytosis in epithelial ovarian carcinoma
    Andrew J Li
    Department of Obstetrics and Gynecology, Cedars Sinai Medical Center, Geffen School of Medicine at UCLA, Los Angeles, CA 90048, USA
    Gynecol Oncol 92:211-4. 2004
    ..Thrombocytosis (platelet counts >400 x 10(9)/l) has been identified as a poor prognostic factor in many cancers. Platelet-secreted factors may contribute to metastasis, invasion, and primary tumor growth...
  6. ncbi Androgen mediation of thrombocytosis in epithelial ovarian cancer biology
    Andrew John Li
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars Sinai Medical Center, Los Angeles, California 90048, USA
    Clin Cancer Res 11:8015-8. 2005
    ..We hypothesized that androgen-mediated thrombocytosis promotes aggressive ovarian cancer biology...
  7. ncbi Ovarian preservation in stage I low-grade endometrial stromal sarcomas
    Andrew J Li
    Department of Obstetrics Gynecology, Cedars Sinai Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90048, USA
    Obstet Gynecol 106:1304-8. 2005
    ..To examine the impact of ovarian preservation in a case-control study of women with stage I low-grade endometrial stromal sarcomas...
  8. doi Impact of androgen receptor cytosine-adenine-guanine polymorphisms on clinical outcome in BRCA mutation-associated epithelial ovarian cancers
    Andrew J Li
    Department of Obstetrics and Gynecology, Cedars Sinai Medical Center, 8700 Beverly Blvd, Suite 160W, Los Angeles, CA 90048, USA
    Gynecol Oncol 116:105-8. 2010
    ..We hypothesized that AR CAG allele length is a modifier of clinical outcome in BRCA1/2 mutation positive women with ovarian cancer...
  9. doi Serum low-density lipoprotein levels correlate with survival in advanced stage epithelial ovarian cancers
    Andrew J Li
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Cedars Sinai Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90048, USA
    Gynecol Oncol 116:78-81. 2010
    ..We have hypothesized that statins influence ovarian cancer outcome through alteration of lipoprotein profiles, and sought to determine correlations between lipoprotein levels and survival in women with advanced stage disease...
  10. ncbi Hereditary ovarian cancer--assessing risk and prevention strategies
    James C Pavelka
    Cedars Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA
    Obstet Gynecol Clin North Am 34:651-65, vii-viii. 2007
    ..In all mutation carriers who have completed or do not desire childbearing, prophylactic bilateral salpingo-oophorectomy must be strongly considered...
  11. ncbi Short androgen receptor allele length is a poor prognostic factor in epithelial ovarian carcinoma
    Andrew J Li
    Department of Obstetrics and Gynecology, Cedars Sinai Medical Center, Los Angeles, California 90048, USA
    Clin Cancer Res 9:3667-73. 2003
    ..Exon 1 of the AR gene contains a polymorphic (CAG)(n) sequence whose length is inversely correlated with transcriptional activity...
  12. ncbi Effect of obesity on survival in epithelial ovarian cancer
    James C Pavelka
    Cedars Sinai Medical Center, Women s Cancer Research Institute at the Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California, USA
    Cancer 107:1520-4. 2006
    ..The current study attempted to determine the influence of excess body weight on ovarian cancer survival, disease progression, and clinicopathologic factors...
  13. ncbi Effect of cigarette smoking on epithelial ovarian cancer survival
    Yevgeniya J M Ioffe
    Department of Obstetrics and Gynecology, Cedars Sinai Medical Center, Los Angeles, California 90048, USA
    J Reprod Med 55:346-50. 2010
    ..To determine associations between smoking and survival in patients with ovarian cancer...
  14. ncbi Chemotherapy in epithelial ovarian cancer
    Jing Wang
    Division of Gynecologic Oncology, Cedars Sinai Medical Center, UCLA School of Medicine, 8700 Beverly Boulevard, 160W, Los Angeles, CA 90048, USA
    Curr Womens Health Rep 2:20-6. 2002
    ..Investigations into novel chemotherapeutic agents and other biologic molecules have led to advances in the therapeutic armamentarium and have improved survival for women with ovarian cancer...
  15. ncbi Peritoneal tuberculosis mimicking advanced-stage epithelial ovarian cancer
    R Geoffrey Elmore
    Department of Obstetrics and Gynecology, David Geffen School of Medicine at University of California, Los Angeles, California, USA
    Obstet Gynecol 110:1417-9. 2007
  16. ncbi Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer
    Allison E Axtell
    University of California Los Angeles UCLA Medical Center, Los Angeles, CA, USA
    J Clin Oncol 25:384-9. 2007
    ..Reciprocally cross validate the predictors identified with those from two previously published cohorts from institutions B and C...
  17. ncbi Tertiary cytoreductive surgery in recurrent ovarian cancer: selection criteria and survival outcome
    Amer K Karam
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Cedars Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048, USA
    Gynecol Oncol 104:377-80. 2007
    ..We sought to evaluate the impact of TCS on survival and to determine predictors of optimal tertiary resection...
  18. ncbi Estrogen and progesterone receptor subtype expression in normal and malignant ovarian epithelial cell cultures
    Andrew J Li
    Department of Obstetrics and Gynecology, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    Am J Obstet Gynecol 189:22-7. 2003
    ..Epidemiologic data suggest that the malignant transformation of ovarian epithelium may be linked to altered steroid hormone homeostasis...
  19. ncbi The prognostic significance of thrombocytosis in uterine papillary serous carcinomas
    Dimitry L Lerner
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Cedars Sinai Medical Center, 8700 Beverly Blvd, Suite 160W, Los Angeles, CA 90048, USA
    Gynecol Oncol 104:91-4. 2007
    ..In light of the similarities between uterine papillary serous carcinomas (UPSC) and EOC, we sought to determine the incidence of thrombocytosis in UPSC and examine associations with clinico-pathologic features and survival...
  20. doi Fluvastatin and cisplatin demonstrate synergistic cytotoxicity in epithelial ovarian cancer cells
    Barbie Taylor-Harding
    Women s Cancer Research Institute and Division of Gynecologic Oncology, Burns and Allen Research Institute, Cedars Sinai Medical Center, Los Angeles, CA, USA
    Gynecol Oncol 119:549-56. 2010
    ..We hypothesized that statins have a cytotoxic effect and that the combination of fluvastatin and cisplatin inhibits cellular proliferation in epithelial ovarian cancer cells...